Home/ Supplements/ Electrolytes/ Super Nu-Thera with P5P and Extra Calciu...

Super Nu-Thera with P5P and Extra Calcium

product on market Tablet or Pill Kirkman Safety: 99/100
99/100

This product looks safe

  • Folate: 333mg is 333.0× the Tolerable Upper Intake Level (1.0mg)
  • 71% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains essential vitamins A, C, D3, E, and B1, which are supported by strong evidence for maintaining immune function and metabolic health. These nutrients act as antioxidants and cofactors for various biological processes. The formulation maintains a high safety score, indicating a low risk of adverse effects at recommended dosages.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folate: 333mg is 333.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Super Nu-Thera with P5P and Extra Calcium
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
180
Servings
Other Combinations
Product Type
71%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
750 mcg RAE (83% DV)
Vitamin C
250 mg (278% DV)
2.5 mcg (13% DV)
Within RDA (0.2× RDA) 608 studies (A:16, B:251)
10 mg (67% DV)
Within RDA (0.7× RDA) 179 studies (A:3, B:90)
7.5 mg (625% DV)
6.2× RDA — above typical dose 76 studies (A:0, B:33)
7.5 mg (577% DV)
5.8× RDA — above typical dose 13 studies (A:0, B:1)
15 mg NE (94% DV)
1.1× RDA — within safe limits 196 studies (A:5, B:63)
75 mg (4412% DV)
57.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
333 mcg DFE (83% DV)
Exceeds UL by 333.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
5 mcg (208% DV)
2.1× RDA — within safe limits 139 studies (A:1, B:44)
50 mcg (167% DV)
1.7× RDA — within safe limits 27 studies (A:0, B:11)
25 mg (500% DV)
5.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
250 mg (19% DV)
50 mcg (33% DV)
Within RDA (0.3× RDA) 245 studies (A:4, B:133)
125 mg (30% DV)
Within RDA (0.3× RDA) 316 studies (A:8, B:159)
5 mg (45% DV)
Within RDA (0.5× RDA) 263 studies (A:6, B:134)
25 mcg (45% DV)
Within RDA (0.5× RDA) 173 studies (A:0, B:67)
0.75 mg (33% DV)
Within RDA (0.3× RDA) 9 studies — no high-quality reviews
50 mg (9% DV)
Within RDA (0.1× RDA) 38 studies (A:1, B:7)
Market median: 500.0mg (9 products) 7 studies — no high-quality reviews
50 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)

Other Ingredients

Microcrystalline Cellulose Sodium Starch Glycolate Stearic Acid Magnesium Stearate Sodium Ascorbate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Take three tablets per day or as directed by a physician.

Warnings & Precautions

Keep out of the reach of children. Caution: Formulated for adults and children four years and older. For children under four consult a physician.

Formulation Notes

Free of: Milk, eggs, fish, shellfish, tree nuts, peanuts, wheat and soy

Gluten-free

Multivitamin & mineral formula

Additional Information

Important: Store in a cool dry place and tightly capped.

Ultra Tested cGMP

503.694.1600

Metadata

Product Details

UPC / SKU8 12325 02115 4
DSLD Entry Date2025-06-25
Product TypeOther Combinations
FormTablet or Pill
BrandKirkman
DSLD ID333058
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.